We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Improved Treatment for Infants With Misshapen Heads

By HospiMedica staff writers
Posted on 27 Sep 2006
An improved treatment option provides surgeons with greater control in reshaping the skull of children suffering from craniosynostosis, a birth defect in which the bones of the skull prematurely close. More...


Traditionally, craniosynostosis has been treated using metal screws and plates. However, pediatric plastic surgeons at Morgan Stanley Children's Hospital of NewYork-Presbyterian (NY, USA) are using absorbable plates made of a combination of polyglycolic and polylactic acid that are absorbed by the body much like surgical sutures. These plates can be placed wherever is necessary, including the forehead bone. Surgery for craniosynostosis is usually performed in the first six months of the child's life for several reasons, including the fact that the bones of the skull are easier to work with at this age. Moreover, the growing brain can continue to reshape the skull and face after the surgery.

"Deformities like a misshapen head can be very traumatic for parents,” said Dr. Jeffrey Ascherman, director of the division of plastic surgery. "It is important for the child's pediatrician to detect the condition early and for parents to seek the best specialized care for their child.”

The causes of craniosynostosis are usually not known. It occurs in many syndromes, including Apert's, Crouzon's, and Pfeiffer's syndromes. However, a distorted head at birth does not always result from craniosynostosis and may require other non-surgical interventions.



Related Links:
Morgan Stanley Children's Hospital

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.